ImmunoMet Therapeutics' Series B Round

ImmunoMet Therapeutics raised a round of funding on March 07, 2017.

ImmunoMet Therapeutics is a development-stage biotechnology company focused on utilizing cellular metabolism to develop anti-tumor and immuno-oncology therapies.…

Articles about ImmunoMet Therapeutics' Series B Round: